PolitiFact @PolitiFact
There's no question U.S. consumers pay far more than those in other countries for insulin. There is strong evidence that drug company profits are a key factor in the higher costs—as well as other factors like the amount of money intermediaries get. https://t.co/KosdJiiw3n — PolitiTweet.org
